SCHEMBL7079042

SCHEMBL7079042

CC(C)(C)OC(=O)N1CCC(NS(=O)(=O)c2cccc(C#N)c2)(C(=O)O)CC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.48
HSD17B10 Q99714 1/20 0.48
NR1H2 P55055 2/20 0.46
STS P08842 1/20 0.46
CYP3A4 P08684 7/20 0.45
CYP1A2 P05177 5/20 0.45
CYP2C9 P11712 4/20 0.45
CYP2C19 P33261 4/20 0.45
USP2 O75604 4/20 0.45
TSHR P16473 3/20 0.45
MAPK1 P28482 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TGFBR1 P36897 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HIF1A Q16665 3/20 0.42
GPR119 Q8TDV5 2/20 0.42
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7079044 0.86 NR1H2 (0.42) CYP2D6HSD17B10NR1H2STSCYP3A4
SCHEMBL27589461 0.86 CYP3A4 (0.48) CYP2D6HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL7082012 0.82 CYP2D6 (0.59) CYP2D6HSD17B10CYP3A4CYP1A2CYP2C9
SCHEMBL6994772 0.80 USP2 (0.53) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL7084134 0.79 KAT6A (0.44) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL6990928 0.79 USP2 (0.55) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL7077236 0.77 MMP1 (0.52) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL7078089 0.76 USP2 (0.44) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL17269893 0.76 NR1H2 (0.56) NR1H2STSTGFBR1GPR119
SCHEMBL19123290 0.76 NR1H2 (0.56) NR1H2STSTGFBR1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162814-A1 N-substituted 1-amino-1,1-dialkylcarboxylic acid derivatives MERCK PATENT GMBH (DE) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162814-A1 N-substituted 1-amino-1,1-dialkylcarboxylic acid derivatives F5, CCNY, F2 CYP2D6 2624/4885HSD17B10 2620/4885NR1H2 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.